Clinical Trials
3 trialsNCT03937154 2026-04-07
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Amgen
Phase 3 Active not recruiting
NCT07048249 2026-03-18
Single Arm Romiplostim to Prevent CIT
Children's Hospital Medical Center, Cincinnati
Phase EARLY_PHASE1 Recruiting
NCT03362177 2026-02-11
RECITE
Amgen
Phase 3 Completed